Please provide your email address to receive an email when new articles are posted on . Two-thirds of patients with relapsed pediatric low-grade glioma treated with tovorafenib responded to therapy, ...

In this second installment of MedPage Today's virtual roundtable series on pediatric low-grade glioma, moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, is joined once ...

Please provide your email address to receive an email when new articles are posted on . Tovorafenib monotherapy induced response among approximately two-thirds of patients with recurrent or ...

An AI tool using temporal learning significantly outperforms traditional methods in predicting pediatric glioma recurrence, achieving 75% to 89% accuracy. The AI model analyzes multiple brain scans ...

Gomekli showed an 87% overall response rate in pediatric low-grade glioma with MAPK pathway activation, with a recommended dose of 3 mg/m2 twice daily. Common adverse effects included weight gain, ...

The US Food and Drug Administration (FDA) has approved dabrafenib (Tafinlar) with trametinib (Mekinist) for children aged 1 year or older who need systemic treatment for low-grade gliomas that have a ...

MedPage Today brought together three expert leaders for a virtual roundtable discussion on pediatric low-grade glioma. Moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, ...

Treatment for glioma has long relied on MRI imaging to track tumor markers and treatment response. But new findings suggest a new method could provide additional data about tumor markers before ...

AGOURA HILLS, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTLC) ("Oncotelic", the "Company" or “We”), a developer of treatments for rare and orphan indications, including ...

Ojemda is the first FDA-approved systemic therapy for pediatric LGG patients with BRAF rearrangements, including fusions. The Food and Drug Administration (FDA) has granted accelerated approval to ...

If your child has been diagnosed with a pediatric low-grade glioma (pLGG), you may be wondering where, exactly, you should go for medical care. For starters, you’ll want to look for a treatment center ...

Researchers at the University of Michigan Rogel Cancer Center have identified a novel treatment approach to an aggressive type of pediatric brain cancer, using therapies already approved to treat ...